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Background To ensure patients and families
receive appropriate end-of-life care pathways and
guidelines aim to inform clinical decision making.
Ensuring appropriate outcomes through the use
of these decision aids is dependent on timely
use. Diagnosing dying is a complex clinical
decision, and most of the available practice
checklists relate to cancer. There is a need to
review evidence to establish diagnostic indicators
that death is imminent on the basis of need
rather than a cancer diagnosis.
Aim To examine the evidence as to how
patients are judged by clinicians as being in the
final hours or days of life.
Design Integrative literature review.
Data sources Five electronic databases
(2001–2011): Cochrane Central Register of
Controlled Trials (CENTRAL) on The Cochrane
Library, MEDLINE, EMBASE, PsycINFO and
CINAHL. The search yielded a total of 576 hits,
331 titles and abstracts were screened, 42
papers were retrieved and reviewed and 23
articles were included.
Results Analysis reveals an overarching theme of
uncertainty in diagnosing dying and two
subthemes: (1) ‘characteristics of dying’ involve
dying trajectories that incorporate physical,
social, spiritual and psychological decline towards
death; (2) ‘treatment orientation’ where decision
making related to diagnosing dying may remain
focused towards biomedical interventions rather
than systematic planning for end-of-life care.
Conclusions The findings of this review support
the explicit recognition of ‘uncertainty in
diagnosing dying’ and the need to work with
and within this concept. Clinical decision making
needs to allow for recovery where that potential
exists, but equally there is the need to avoid
futile interventions.
Improving end-of-life care is a key pri-
ority within current health and social
care policy across European countries.1 2
A shared focus is quality of care and pro-
vision based on need rather than diagno-
sis. Service providers are required to
ensure that, when death is inevitable,
every patient receives appropriate and
timely end-of-life care, focused on
comfort and dignity while avoiding futile
and invasive interventions that prevent a
peaceful death. The importance of pre-
paring and supporting the family and
those close to the patient is also recog-
nised as directly influencing how they
cope with and adapt to bereavement,
with implications for their health and
social well-being.3–6
Measures towards improving the
quality of care in the last days and hours
of life include the introduction of multi-
professional integrated care pathways to
benchmark standards and support the
delivery and evaluation of clinical care.
The Liverpool Care Pathway (LCP) for
the Dying Patient is the most widely
recognised.7 Originally developed within
the UK in the mid-1990s as a vehicle to
transfer the hospice model of end-of-life
care for cancer patients into general care
settings, the LCP came to be regarded as
a model of best practice and is now used
internationally.8–10
Identifying that the patient may be
dying is, however, the crucial first step to
planning and delivering effective
end-of-life care, including the use of care
pathways such as the LCP. Clinicians must
accurately diagnose dying in order to
ensure that a high standard of end-of-life
care is provided for all those who need it
and equally to identify when restorative
treatment aims are appropriate.11 12 This
process is currently viewed as part art,
part science and is often regarded as a
skill of individuals rather than an object-
ive assessment of signs and
symptoms.12 13
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The complexity of diagnosing dying has been high-
lighted within recent reviews of the LCP, which report
some difficulties and misinterpretations in relation to
the purpose and use of this framework in practice. A
focus of attention is clinical decision making sur-
rounding end-of-life care, with key recommendations
including the development of clear guidance for pro-
fessionals and further research in diagnosing
dying.14 15
This integrative review was conducted to inform
evidence-based practice in diagnosing dying,
prompted by clinical members of the review team
involved in supporting end-of-life care across hospital,
hospice and community settings. The findings are also
timely in relation to European policy requirements
and relevant to informing the development and gov-
ernance of end-of-life care internationally, reflecting




The aim of this integrative review was to examine the
nature of evidence available to identify how patients
are judged by clinicians as being in the final hours or
days of life. The following questions formed the basis
of the review:
▸ How do clinicians diagnose dying?
▸ What factors influence clinical decision making about
dying?
▸ Can any related tools, triggers or guidance for clinicians
be sourced?
An important facet of this review was the inclusion
of evidence from a range of chronic progressive con-
ditions across the advanced disease trajectory. The
outcomes of this review are presented in a conceptual
map (figure 1) constructed using an inductive
approach to illustrate the key concepts derived from
the narrative synthesis of key literature and the rela-
tionships between these. This provides the reader with
a conceptual framework that illustrates antecedents to
clinical decision making in the complex process of
diagnosing dying, when death can be anticipated.
Given the scope of the review questions, key aspects
of the systematic review methods advocated by the
Cochrane Collaboration and Scottish Intercollegiate
Guideline Network (SIGN) were tailored to an inte-
grative review design.17 18 While the systematic
review of randomised controlled trials is considered
to be the gold standard in research synthesis, the inte-
grative review is increasingly recognised as appropriate
to inform evidence-based practice. The integrative
review synthesises findings from a diverse range of
primary experimental and non-experimental research
methods to provide breadth of perspectives and a
more comprehensive understanding of a complex
healthcare problem.19 Our review was based on the
steps and processes in box 1 and informed by the
PRISMA standards for reporting systematic reviews.20
Search strategy and results of search
The search of electronic databases was comprehensive
and included the Cochrane Central Register of
Controlled Trials (CENTRAL) on The Cochrane Library,
MEDLINE (1950–2011), EMBASE (1980–2011),
PsycINFO (1980–2011), CINAHL (1982–2011), Web
of Science and Google (to September 2012*). Key
search terms included combining *diagnosis (MeSH
Diagnos*) with Death*, dying and care. End of life*
was combined with Diagnos* and key words such as
Recognis* and Instrument*. The search strategy is
detailed in box 2. Results from Web of Science and
Google were subsequently removed as the search of
other databases was discriminating enough and these
Figure 1 Conceptual map of findings.
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two databases did not allow us to combine the MeSH
and key search terms resulting in an unmanageable
numbers of irrelevant hits.
We included systematic reviews, qualitative and
quantitative studies that explored how patients are
judged by clinicians as being in the final hours or days
of life. The population investigated was adult patients
with progressive life-limiting illness in hospital,
hospice, community or care home settings. Our focus
was to establish what factors influence clinical deci-
sion making by health professionals in determining
when a patient is in the dying phase, including any
tools, triggers or guidance. Papers that focused on the
transition to palliative care and prognostication were
excluded, as beyond our aim to extract data relevant
to the last hours or days of life. Literature about the
LCP was included where this considered diagnosing
dying and therefore met the inclusion criteria for the
review.
The search included literature published since 2001
in English from Europe, North America and
Australasia as these were judged to be culturally rele-
vant to a European context. A 10-year timescale was
considered sufficient to ensure comprehensive cover-
age and currency of relevant literature given the
increasing emphasis during this timeframe on plan-
ning end-of-life care. The initial search strategy gener-
ated 576 titles. In total, 245 titles were excluded due
to being duplicates or not relevant to the overall aims
of the review by three reviewers (CK, CG and PBY)
who screened the original yields from the searches.
These three reviewers independently reviewed 331
abstracts and agreed initial inclusion of papers in the
review at a consensus meeting. In addition to the
place and year of publication, papers had to explore
diagnosing dying (the dying phase: last hours or days
of life) in adults rather than the transition to palliative
care where prognosis was a longer term. At this stage,
42 papers were identified and further scrutinised.
Nineteen papers were excluded because they did not
present data about the last hours and days of life and
this rendered 23 papers for inclusion (figure 2).
Searches of grey literature identified a number of con-
ference posters and some work in progress. Authors
were contacted where possible, but this yielded insuf-
ficient or no further data for inclusion.
Review process and quality assurance
Once the 23 papers for inclusion were identified, the
eight reviewers were paired and each pair reviewed 5–
6 studies through extracting key data and findings
using a preformatted table (see online supplementary
table S1). This was an important part of the quality
assurance process as ensuring all reviewers used a con-
sistent approach to data extraction. Reviewers first
read their allocated studies independently then agreed
findings with a partner, which were presented in a
summary table. This produced 23 summaries, one for
each included study. We used the SIGN hierarchy of
evidence to assign a quality rating to the papers in
order to allow us to draw conclusions and make an
Box 1 Methods of the integrative review
▸ Aims for the review are identified
▸ Criteria for including studies were identified
▸ Literature was identified according to an explicit and
robust search strategy that was subject to ongoing
refinement
▸ Studies were selected according to inclusion/exclusion
criteria
▸ Studies were summarised using an agreed format
and key messages were extracted
▸ Data extraction was undertaken by two reviewers
▸ We present a summary and synthesis of relevant
studies
▸ Thematic analysis was an ongoing and iterative
process involving all team members.
Box 2 Search strategy
1. (Death AND (Sign* OR symptom*))
2. (Dying AND (Sign* OR symptom*))
3. 1 OR 2
4. 3 AND Diagnos*
5. 3 AND Recognis*
6. 3 AND Assess*
7. 3 AND Tool
8. 3 AND Instrument*
9. 3 AND Criteria
10. 3 AND Pathway*
11. 3 AND Care
12. 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11
13. End of Life AND Diagnos*
14. End of Life AND Recognis*
15. End of Life AND Assess*
16. End of Life AND Tool
17. End of Life AND Instrument*
18. End of Life AND Criteria
19. End of Life AND Pathway*
20. End of Life AND Care
21. 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20
22. 12 AND 21
23. 22 AND Palliative
24. 22 AND Terminal*
25. 22 AND Final
26. 22 AND Cancer*
27. 22 AND Coronary
28. 23 OR 24 OR 25 OR 26 OR 27
29. Limit 28 to Human, English Language, 2001–2011,
and Primary Studies, Meta-Analyses, Systematic
Reviews, RCTs, Europe, North America, Australasia.
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overall judgement about the quality of evidence avail-
able in the field. All reviewers received detailed sum-
maries of all the included papers and then
participated in the refinement of themes and a con-
ceptual framework initially developed by three
reviewers (CK, CG and PBY). Robust methods were
employed throughout the review, with analysis an
ongoing and iterative process involving all team
members. This included two full-team consensus
meetings via teleconference, in addition to ongoing
dialogue and feedback via email.
RESULTS
A central overarching theme of uncertainty in diag-
nosing dying emerged, alongside two subthemes,
characteristics of dying and treatment orientation.
What follows is the presentation of the thematic and
conceptual findings from the review process.
Review findings on ‘characteristics of dying’
Thirteen papers identified characteristics of dying:
one systematic review,21 seven retrospective chart
reviews,
22–27 two qualitative studies,28 29 one struc-
tured interview study,30 one quantitative study,31 one
literature review32 and one survey.33 The review by
Plonk (2005) included all research relevant to death,
terminal care and bereavement available on Medline
between 1990 and 2004; two studies focused on older
people in the nursing home setting29 30 and four studies
focused on cancer (Ethunandan et al 2005):24 25 27 31
one on patients with stroke (Mazzocato et al 2010)26 ,
three on both cancer and other long-term conditions
(Goodman et al 2002)23 28 32, one on amyotrophic
lateral sclerosis (ALS)22 and one on medical decision
making at the end of life.33
Findings from these studies demonstrate dying tra-
jectories that incorporate physical, social, spiritual and
psychological decline towards death and the extent to
which each study dealt with these varied.
Physical characteristics included symptoms such as
dyspnoea, which was correlated with shorter survival
across cancer and other diagnoses such as ALS and
may be a marker of the final phase of the dying
process.22 23 Chart reviews of 42 patients with stroke
showed multiple causes of dyspnoea such as aspiration
pneumonia or cardiac failure, which were a major or a
contributing cause of death in 78% of these
patients.26 Physical decline and symptoms such as
pain, loss of appetite and increased dependency are
also reported as more prevalent shortly before death
in patients with cancer.31
Glioma patients have particular physical rather than
psychosocial symptoms such as decreased level of con-
sciousness, dysphagia, neurological deficit and seizures
in the last phase of life. Tailored guidelines may then
be required for this group of patients to inform antici-
patory care planning and treatment decisions at the
end of life.25 27
A number of studies identified that for both cancer
and non-cancer patients psychosocial characteristics
were present but received less attention at the end of
life. These included issues with coping, struggling
with the meaning and purpose of life, impaired cogni-
tion and conscious level.28–31 While the relationship
between physical and psychosocial symptoms such as
pain and existential or psychosocial suffering remains
poorly studied, there is increasing evidence of medical
interventions at the end of life.21 33
The relationship between physical and psychosocial
symptoms also emerged in a UK study of patients with
heart failure (n=24) and patients with lung cancer
(n=24). Issues relating to the meaning and purpose of
life may be perceived by patients as more important
than physical well-being, symptoms or support near
the end of life. As physical symptoms increased, there
was a parallel decline in social well-being, with social
withdrawal identified as an independent marker of the
immanence of death. In patients with lung cancer, the
physical and social care trajectories were interlinked
with psychological and spiritual issues and this became
more evident at times of transition, including to the
final phase of the illness. Similarly, for patients with
heart failure, social and psychological decline ran in
parallel with physical deterioration.28 As noted for
patients with head and neck cancer (N=32), insuffi-
cient recording of the psychosocial and spiritual
aspects of care means that the ‘complete quality of
dying’ experience cannot be assessed.24
The influence of perceived suffering on medical
decision making was revealed in a large survey
(n=20 480) of doctors across six European coun-
tries.33 The proportion of deaths preceded by deci-
sions made in response to suffering (as perceived by
the doctors rather than an explicit request from the
patient) varying between 23% (Italy) to 51%
(Switzerland). Sudden and unexpected death occurred
in about a third of cases in all six countries. The
administration of drugs with the explicit intention of
hastening death varied between countries: about 1%
or less in Denmark, Italy, Sweden and Switzerland;
1.82% in Belgium and 3.40% in the Netherlands.
Figure 2 Search results.
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Residents in nursing homes experience high rates of
physical and emotional symptoms at the end of life,
which may not be well-managed, as in this setting the
interpretation of ‘comfort care’ can vary and
end-of-life care needs may not then be recognised or
addressed.29 30 In the frail elderly, physical indicators
were identified as anorexia, increased pain, greater
frailty or weakness, weight loss, altered breathing pat-
terns (including apnoea), mottled skin and a distinct-
ive odour. Behavioural indicators include personality
and mood changes, with increased restlessness,
anxiety or agitation described as characteristics of the
final decline to death. Withdrawal from conversation
with staff and a new tendency to decline social inter-
action with other residents or family members was
also identified. For people with dementia, an integra-
tive literature review highlighted a range rather than
definitive characteristics of dying and little consensus
regarding the value of prognostic indicators.32
One study explored the application of the Palliative
Performance Scale (PPS) to predict death/length of
survival in a hospital setting for patients with cancer
(n=157) and other diagnoses (n=104). Health profes-
sionals were more likely to regard cancer as a terminal
illness than other groups, and while the PPS was
useful in describing mortality risk across populations,
it is less useful for predicting death in individual
patients.23
The included studies identified a range of physical
and psychosocial characteristics of dying. There was
variability in recording and measurement including
factors such as severity and progression rate. No
definitive criteria for diagnosing dying were identified
across all patient groups. Professional decision making
may also be influenced by the diagnosis of the patient
and care setting. A cancer diagnosis may prompt the
health professional to look for confirming evidence
that death may be imminent as opposed to other life-
limiting conditions, particularly in frail older people
who may receive comfort, rather than end-of-life care.
Evidence also suggests that a focus on physical symp-
toms may also support the tendency towards ongoing
biomedical interventions despite the imminence of
death. This is explored further in the second sub-
theme; treatment orientation.
Review findings on ‘treatment orientation’
Ten papers reported findings on the factors influen-
cing end-of-life decision making including diagnosing
dying, care and symptom management.
Methodologies were two case reviews,34 35 one
exploratory interview study,36 two mixed
methods,37 38 one quantitative study,39 one retrospect-
ive cross-sectional survey of bereaved relatives,40 one
qualitative study,41 one action research study42 and
one case review of patients on LCP.43
Findings from these papers suggest that while
nurses and doctors may diagnose dying or report
being able to do so, medically futile interventions may
be continued in the very last phase of life.36–38 Where
poor prognosis and the dying phase was recognised
and documented, there was still little evidence of sys-
tematic planning for end-of-life care. Consequently,
diagnostic testing and unnecessary interventions were
continued in the last 24 h of life.37 A German study
of medical and nursing practice in caring for dying
patients (n=252) in a large hospital identified that
plans for end-of-life care were implemented rarely and
late. Fifty-two per cent of patient died in ICU with a
focus on life-prolonging interventions evident.34 In
Italy, a review of the medical and nursing records of
the last 3 days of life for 370 patients reported that
patients were exposed to invasive treatments despite
close proximity to death and with palliative care
expertise sought in only 7% of cases.38 Large varia-
tions have also been recorded regarding the extent to
which decisions are discussed with patients, relatives
and other caregivers and the need for much greater
involvement of patients and families in end-of-life
decision making acknowledged.33
The influence of diagnosis on professional
responses was also identified from a survey of
bereaved carers.35 In contrast to patients with cancer,
those with other life-limiting illnesses were less likely
to be diagnosed as dying and more likely to be moved
to hospital prior to death.40 Older patients in the end
stages of heart failure or dementia admitted through
accident and emergency departments (n=102) have
been reported as disadvantaged in relation to timely
end-of-life care.35
Three included papers were linked to implementa-
tion of the LCP.41–43 A retrospective review of patient
data (n=168) in one hospice reported the LCP entry
criteria as appropriate for a cancer population; com-
bining multiprofessional team agreement that the
patient is dying with additional criteria including bed-
bound, semi-comatose and only able to take sips of
fluid.43 These criteria were supported by a phenom-
enological study of hospice doctors and nurses
(n=10), which also highlighted the influence of add-
itional factors. These included understanding the indi-
vidual patient’s history, the experience of the clinician
and the views of family and carers. Staff experienced
anxiety over potential mistiming of the LCP and
causing distress for patients and families. The authors
suggest the risk that clinicians may then avoid difficult
conversations with families struggling to accept the
reality of dying.41 An action research study in eight
UK nursing homes identified a functional rehabilita-
tive culture and that staff lacked knowledge and skills
related to diagnosing dying and end-of-life care that
made implementation of the LCP challenging, requir-
ing a cultural shift, change to care processes and facili-
tative education.42
Implementation of the Inpatient Comfort Care
Program (ICCP) (preintervention n=108;
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postintervention n=95) suggests it may be possible to
introduce palliation in hospital units focused on cura-
tive interventions that positively impacts on end-of-life
care, although the primary outcomes stated are linked
to physical as opposed to psychosocial symptoms. The
primary process of care, presence of an order for
opioid medication at the time of death, showed a
highly significant change from 57.1% to 83.2%.
Presence of a do not resuscitate order at the time of
death increased from 61.9% to 85.1%, with indica-
tors that most of the dying patients were recognised
and their preferences for end-of-life care documented
to 90.8%. Improved documentation suggested that
the intervention was successful in stimulating staff to
recognise symptoms and better identify patients who
are dying.39
It is noteworthy that seven of the papers focus on
acute hospital settings, and despite the limited
number of studies, decision making related to diag-
nosing dying in this setting may remain focused
towards biomedical interventions rather than system-
atic planning for end-of-life care. There is some evi-
dence, however, that while factors such as the context
of care and the diagnosis of the patient may influence
decision making, measures including education and
supportive care processes can facilitate appropriate
end-of-life care.
Conceptual map of key findings
Synthesis of the findings revealed a number of antece-
dents to decision making and possibilities for action.
The conceptual framework (figure 1) provides a visual
representation of the possible relationships between
decisions, responses and strategies that are influenced
by the clinical context. The evidence of active medical
intervention rather than end-of-life care reported in
several studies we interpreted as resulting from ‘uncer-
tainty in diagnosing dying’ due to a number of factors
that can influence decision making and responses.
Care orientation in an acute hospital is more likely to
result in active treatment as opposed to the nursing
home, where comfort or rehabilitative care may be
the focus. Our findings demonstrate that diagnosis is
important, with cancer linked to more explicit recog-
nition of dying than other life-limiting illnesses.
Professionals’ expertise in end-of-life care is also
important in determining their course of action.
DISCUSSION
The overarching theme of ‘uncertainty in diagnosing
dying’ is representative of the current discourse within
literature and echoes our limited understanding of
what constitutes a ‘good death’.24 It also reflects a ten-
dency towards continued unnecessary interventions
and treatment into the last days of life, even when
nurses and doctors recognise death is imminent.44
The complexity of identifying clinical indicators of
dying across different diseases supports the drive
towards care based on needs rather than diagnosis.21 37
However, expanding our understanding of the
characteristics of dying for different patient groups is
important to support thorough and comprehensive
clinical assessments, determining whether reversible
causes for decline are present and can be addressed or
whether death may be imminent.45 Of consideration,
however, is the need for consensus regarding termin-
ology. A range of terms may be used for the final
phase of life, with varied and often implicit rather
than clearly stated definitions, which can confound
synthesis of evidence and cause ambiguity in relation
to care goals.46
Of relevance to the current discourse regarding the
LCP, this review has highlighted a range of contextual
factors that may influence diagnosing dying reflecting
calls for research in this area.14 47 The first rando-
mised controlled trial to assess the effectiveness of the
LCP reported no significant difference in the overall
quality of end-of-life care for people with cancer and
highlighted the influence of contextual factors.9 The
authors also question whether focusing only on the
last few hours or days of life may influence optimum
management for those with difficult symptoms and
communication with the family. This reflects earlier
discourse from 2001 and further supports the need
for clarification of current definitions to reflect the
temporal nature of dying.43
For patients and families, planned care in place of
choice, time with loved ones to say goodbye and
being prepared to die are recognised as important at
the end of life.31 Yet, even when death may be immi-
nent, there remains a tendency for professionals to
avoid or postpone related conversations, reflecting the
reality that many care decisions are informed by role
and personal world views.36
The importance of exposing uncertainty in diagnos-
ing dying cannot be overly emphasised. It is an
important consideration for the individual clinician
and the healthcare team, but equally for patients and
carer(s). Allowing the possibility of death to be
acknowledged and any plan of treatment to be dis-
cussed realistically gives precious time for the patient
and family to express their preferences. This facilitates
an individualised plan of care, particularly where no
restorative treatment is possible or further decline
would herald the end of life. Paradoxically, being
open about uncertainty may support planning and
build trust with the patient and their carer(s), remov-
ing the need to rely on a ‘tick box’ approach to diag-
nosing dying.14 45
Thus, strategies used to reduce uncertainty should
reflect that decision making is influenced by clinical
skills, professional judgement and clinical wisdom. In
this context, clinical wisdom describes a depth of intui-
tive expertise, reflective of a strong skill base, which
frames the decision-making process. Clinical wisdom is
evident when symptoms are potentially reversible or
Review
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when the reality of dying is in evidence and a decision
on the right course of action is needed. Clinical
wisdom assists in determining appropriate goals of care
and interventions to ensure that the patient’s wishes
are met and a dignified death is achieved.48
CONCLUSION
The findings of this review support the explicit recogni-
tion of ‘uncertainty in diagnosing dying’ and the need
to work with and within this concept. Clinical decision
making needs to allow for recovery where that potential
exists, but equally there is the need to avoid futile inter-
ventions. This requires contextual factors to be
addressed, reliable care processes and systems and edu-
cation for healthcare professionals alongside raising
public awareness of issues related to death and dying.
Most of the included studies were based on retro-
spective case reviews or small qualitative studies and
scored low/moderate quality ratings, and the findings
should be viewed in this context. The search strategy
and methods for synthesising a disparate collection of
studies have limitations. However, we have reported
our methods in detail and consistent patterns emerged
to illustrate important insights into diagnosing dying.
The conceptual map requires further testing and
refinement but provides a basis for further explor-
ation. It also has the potential to provide a framework
for discussion in clinical teams around strategies for
improvement in diagnosing dying.
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